AlphaCrest Capital Management’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$128K Buy
2022
Q1
Sell
2021
Q4
$1.28M Buy
2021
Q3
Sell
2021
Q2
$1.06M Buy
2021
Q1
$636K Sell
2020
Q4
$840K Sell
2020
Q3
$1.07M Buy
2020
Q2
$396K Sell
2020
Q1
$516K Buy
2019
Q4
$278K Buy